Tradestie Institutional Equity Comparison Engine

TCMD vs PMI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TCMD Overall Edge

TCMD Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tactile Systems Technology, Inc. (TCMD) driven by superior Valuation, Growth & Margin, Options & Structure while PMI counters with relative strength in Momentum & Technical. Fundamentally, TCMD trades at 17.7x Forward P/E with 9.4% operating margin (+7.1% YoY revenue) versus PMI at N/M Forward P/E and -248.1% operating margin (+38.6% YoY). In options structure, TCMD sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro) against PMI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner TCMD
TCMD 17.7x vs PMI N/M Fwd P/E
Growth & Margin Winner TCMD
Op Margin 9.4% vs -248.1% ยท YoY +7.1% vs +38.6%
Momentum & Technical Winner PMI
1Y +12.1% vs +107.2% ยท 52W Pos 32% vs 34%
Options & Structure Winner TCMD
CONSOLIDATION (15th %ile IV) vs UNCLASSIFIED (N/A IV)
TCMD NASDAQ
Tactile Systems Technology, Inc.
Surgical & Medical Instruments & Apparatus
$25.99
-1.63% 1D
Market Cap $587.6M
1M Return +11.64%
1Y Return +12.07%
Forward P/E 17.7x
Unified AI Score
36.5 / 100 SELL
Tech 30.0 Fund 40.0 Flow 66.0 Mom 21.1
PMI NYSE American
Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus
$6.30
-2.17% 1D
Market Cap $17.1M
1M Return -34.58%
1Y Return +107.24%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 39.0 Fund 45.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TCMD +12.07% PMI +107.24% Spread: +135.96 pp (PMI Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period TCMD Revenue PMI Revenue TCMD Op. Margin PMI Op. Margin Margin Edge
FY2018 $140M N/A 2.1% N/A TCMD
FY2019 $190M N/A 5.5% N/A TCMD
FY2020 $190M N/A -1.9% N/A TCMD
FY2021 $210M N/A -0.8% N/A TCMD
FY2022 $250M N/A -5.2% N/A TCMD
FY2023 $270M N/A 6.6% N/A TCMD
FY2024 $290M $0M 7.6% -312.3% TCMD
FY2025 $330M $0M 8.9% -268.4% TCMD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TCMD (6) vs PMI (4)
Institutional Metric TCMD PMI Criterion Row Winner
Market Capitalization Scale $587.6M $17.1M Larger Scale TCMD
Trailing P/E Ratio Valuation 25.5x 2.9x Lower Multiple PMI
Forward P/E Ratio Valuation 17.7x N/M Lower Multiple TCMD
Revenue Growth (YoY) Growth +7.1% +38.6% Higher Growth PMI
Operating Margin (TTM) Profitability 9.4% -248.1% Higher Margin TCMD
Net Profit Margin Profitability 6.7% 0.0% Higher Margin TCMD
Return on Equity (ROE) Capital Efficiency 11.0% 0.0% Higher ROE TCMD
52-Week Range Position Momentum 32% ($21โ€“$38) 34% ($0โ€“$18) Stronger Trend PMI
Beta / 30D Volatility Risk Regime 0.99ฮฒ ยท 52% Vol 54.06ฮฒ ยท 134% Vol Lower Realized Risk TCMD
Unified Institutional Score Composite Signal 36.5 / 100 (SELL) 48.4 / 100 (HOLD) Higher Composite PMI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TCMD vs PMI Buy Guide
TCMD CONSOLIDATION
97d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live TCMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PMI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PMI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TCMD nor PMI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.